Creatine
- Generic Name
- Creatine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C4H9N3O2
- CAS Number
- 57-00-1
- Unique Ingredient Identifier
- MU72812GK0
- Background
An amino acid derivative that occurs in vertebrate tissues and in urine. In muscle tissue, creatine generally occurs as phosphocreatine. Creatine is excreted as creatinine in the urine.
- Indication
For nutritional supplementation, also for treating dietary shortage or imbalance.
- Associated Conditions
- -
- Associated Therapies
- -
Creatine Therapy for Huntington's Disease
Phase 1
Completed
- Conditions
- First Posted Date
- 2001-11-16
- Last Posted Date
- 2006-08-18
- Target Recruit Count
- 64
- Registration Number
- NCT00026988
- Locations
- 🇺🇸
Peter Como, Ph.D., Rochester, New York, United States
🇺🇸Andrew Feigin, M.D., Long Island, New York, United States
🇺🇸Karen Marder, M.D., New York, New York, United States
Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]
Phase 2
Completed
- Conditions
- First Posted Date
- 2000-05-29
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Registration Number
- NCT00005674
- Locations
- 🇺🇸
Washington University, St. Louis, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath